Klinger Shannon Thyme, CLO, reported an open-market or private sale at Moderna, Inc. involving 3471.000000 shares for an estimated $485766.45. Reported holdings after the transaction were 74129.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chief Legal Officer
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.
Restricted stock units convert into common stock on a one-for-one basis.
Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
0 other filings
0 recent txs